Fever Control Using External Cooling in Septic Shock
- 15 May 2012
- journal article
- research article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 185 (10), 1088-1095
- https://doi.org/10.1164/rccm.201110-1820oc
Abstract
Fever control may improve vascular tone and decrease oxygen consumption, but fever may contribute to combat infection. To determine whether fever control by external cooling diminishes vasopressor requirements in septic shock. In a multicenter randomized controlled trial, febrile patients with septic shock requiring vasopressors, mechanical ventilation, and sedation were allocated to external cooling (n = 101) to achieve normothermia (36.5-37°C) for 48 hours or no external cooling (n = 99). Vasopressors were tapered to maintain the same blood pressure target in the two groups. The primary endpoint was the number of patients with a 50% decrease in baseline vasopressor dose after 48 hours. Body temperature was significantly lower in the cooling group after 2 hours of treatment (36.8 ± 0.7 vs. 38.4 ± 1.1°C; P < 0.01). A 50% vasopressor dose decrease was significantly more common with external cooling from 12 hours of treatment (54 vs. 20%; absolute difference, 34%; 95% confidence interval [95% CI], -46 to -21; P < 0.001) but not at 48 hours (72 vs. 61%; absolute difference, 11%; 95% CI, -23 to 2). Shock reversal during the intensive care unit stay was significantly more common with cooling (86 vs. 73%; absolute difference, 13%; 95% CI, 2 to 25; P = 0.021). Day-14 mortality was significantly lower in the cooling group (19 vs. 34%; absolute difference, -16%; 95% CI, -28 to -4; P = 0.013). In this study, fever control using external cooling was safe and decreased vasopressor requirements and early mortality in septic shock.Keywords
This publication has 44 references indexed in Scilit:
- Corticosteroids in the Treatment of Severe Sepsis and Septic Shock in AdultsJama-Journal Of The American Medical Association, 2009
- Vasopressin versus Norepinephrine Infusion in Patients with Septic ShockNew England Journal of Medicine, 2008
- Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008Intensive Care Medicine, 2007
- Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trialThe Lancet, 2007
- Sepsis in European intensive care units: Results of the SOAP study*Critical Care Medicine, 2006
- Current Epidemiology of Septic ShockAmerican Journal of Respiratory and Critical Care Medicine, 2003
- Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial*Critical Care Medicine, 2003
- Reversal of late septic shock with supraphysiologic doses of hydrocortisoneCritical Care Medicine, 1998
- Incidence, Risk Factors, and Outcome of Severe Sepsis and Septic Shock in AdultsPublished by American Medical Association (AMA) ,1995
- THE STUDY OF THE FEVERS OF THE SOUTH.JAMA, 1896